Welcome to Quest Diagnostics

The world’s leader in diagnostic
testing, information, and services

services

En Español

Make appointment Change / cancel appt Find a location Get my results
in the spotlight
Blueprint for Wellness™

HEALTH TESTING YOU CHOOSE™ - Get an assessment of your personal health based on laboratory tests and diagnostic test kits that you can order directly online. You can have the results of the tests that you register for made available to you via the web or via other electronically retrievable means, or have printed reports mailed to you. Wellness panels and tests qualify for Flexible Spending Account reimbursement. Take action today, share the "health" with family and friends.

ePrescribing can help you qualify for the CMS 2% incentive payment. Learn more.

Physicians: ePrescribing can help you qualify for the CMS 2% incentive payment. Learn more >

Register now for the Case-oriented Symposium on Bleeding and Thrombosis. Topics include pharmacogenetics to optimize anticoagulant therapy, platelet disorders, aspirin resistance, von Willebrand Disease, Lupus Anticoagulants, women's health issues, and pediatric hemostasis. March 18-19, 2010. Continuing education credit.

Register now for the Case-oriented Symposium on Bleeding and Thrombosis. Topics include pharmacogenetics to optimize anticoagulant therapy, platelet disorders, aspirin resistance, von Willebrand Disease, Lupus Anticoagulants, women's health issues, and pediatric hemostasis. March 18-19, 2010. Continuing education credit.

Use our Drug Testing Return on Investment Calculator to learn how much money your company can save with a drug testing program through Quest Diagnostics.

Use our Drug Testing Return on Investment Calculator to learn how much money your company can save with a drug testing program through Quest Diagnostics.

Physicians: Empower your patients to get their results online and take a more active role in their health.
Patients: Get your lab results online with: Google Health™, Keas™, MicroSoft®, HealthVault™ or Quest Diagnostics’ MyCare360.

Physicians and patients: Learn about testing options for the 2009 H1N1 Influenza Virus.

Read the latest Quest Diagnostics Health Trends™ Report about the behavior of the 2009 H1N1 flu virus, based on our testing data.

Watch the video "Beat the Disease to the Market" to learn Quest Diagnostics' approach to developing diagnostics for infectious diseases.

news

Quest Diagnostics Reports Strong Performance for Fourth Quarter and Full Year 2009; Provides Guidance for 2010

- Fourth quarter diluted EPS grew 11% on revenue growth of 2.7%; cash from operations totaled $360 million
- Full year diluted EPS grew 20% on revenue growth of 2.8%; cash from operations totaled $1 billion
- 2010 EPS expected to be between $4.10 and $4.30 per diluted share
- Listen to a replay of Quest Diagnostics' Fourth Quarter Conference Call
- Read a Transcript of Company Prepared Comments

Quest Diagnostics Increases Share Repurchase Authority By $750 Million

Quest Diagnostics Introduces Molecular Blood Test for Aiding Colorectal Cancer Detection

End of H1N1 "Second Wave" in Sight in the U.S., According to Quest Diagnostics

- Quest Diagnostics Health Trends™ Report shows 75 percent decline in rates of 2009 H1N1 influenza virus testing, but H1N1 is still the predominant influenza strain infecting Americans

Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition

- Research to expand Leumeta™ line of blood plasma diagnostics; Scientists also describe technique for predicting response to Heparin surrogate